ARS Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch ARS Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria (NCT06927999) | ARS Pharmaceuticals, Inc. | 2025-07-09 |
| Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy (NCT06834165) | ARS Pharmaceuticals, Inc. | 2025-05-20 |
| Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares (NCT05496465) | ARS Pharmaceuticals, Inc. | 2022-07-28 |
| Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma (NCT05363670) | ARS Pharmaceuticals, Inc. | 2022-07-28 |
| Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection (NCT04930900) | ARS Pharmaceuticals, Inc. | 2021-08-09 |
Track ARS Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.